Scandion Oncology announces that its President & CEO has bought 4,500 shares in Scandion Oncology
Scandion Oncology A/S (“Scandion Oncology”) announces that its President & CEO, Bo Rode Hansen, has bought additional 4,500 shares in Scandion Oncology resulting in a total holding on 40,400 shares in the Company. For further information regarding Scandion Oncology A/S, please contact: Bo Rode Hansen, President & CEO Phone: +45 3810 2017 E-mail: info@scandiononcology.com Website: www.scandiononcology.com The information was provided by the contact person above for publication on July 19, 2021. About Scandion Oncology A/SScandion Oncology A/S is a clinical Phase